Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure. Business rescue consultant Karl Gribnitz...
The AIDS drug tender reveals challenges in supply continuity due to Avacare subsidiaries entering business rescue. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
